Picton Mahoney Asset Management’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-187,500
Closed -$15K 562
2023
Q1
$15K Hold
187,500
﹤0.01% 402
2022
Q4
$1K Hold
187,500
﹤0.01% 663
2022
Q3
$23K Hold
187,500
﹤0.01% 604
2022
Q2
$20K Hold
187,500
﹤0.01% 702
2022
Q1
$66K Buy
+187,500
New +$76K ﹤0.01% 700

Picton Mahoney Asset Management's LVACW Position: Q2 2023 in Review

Picton Mahoney Asset Management sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 187,500 shares — an estimated $15K sold.

Picton Mahoney Asset Management first reported a position in LVACW in Q1 2022 and held it in 5 quarters. The position peaked at $66K in Q1 2022. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

  • Picton Mahoney Asset Management reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 187,500 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $15K.
  • Picton Mahoney Asset Management first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q1 2022 and held it in 5 quarters.
  • Picton Mahoney Asset Management's LAVA Medtech Acquisition Corp. Warrants position peaked at $66K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2023, filed 3 Aug 2023.